Cargando…

The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.

Buddleja lindleyana Fort., a traditional Chinese medicine, has demonstrated anti-inflammatory, immunomodulatory, antidementia, neuroprotective, antibacterial, and antioxidant effects. Its flowers, leaves, and roots have been used as traditional Chinese medicines. A simple and rapid high-performance...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xia, Zhang, Zhi-qing, Zhang, Li-cang, Wang, Ke-xin, Zhang, Lan-tong, Li, De-qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037101/
https://www.ncbi.nlm.nih.gov/pubmed/35479475
http://dx.doi.org/10.1039/d1ra04154a
_version_ 1784693659842641920
author Zhang, Xia
Zhang, Zhi-qing
Zhang, Li-cang
Wang, Ke-xin
Zhang, Lan-tong
Li, De-qiang
author_facet Zhang, Xia
Zhang, Zhi-qing
Zhang, Li-cang
Wang, Ke-xin
Zhang, Lan-tong
Li, De-qiang
author_sort Zhang, Xia
collection PubMed
description Buddleja lindleyana Fort., a traditional Chinese medicine, has demonstrated anti-inflammatory, immunomodulatory, antidementia, neuroprotective, antibacterial, and antioxidant effects. Its flowers, leaves, and roots have been used as traditional Chinese medicines. A simple and rapid high-performance liquid chromatography method coupled with mass spectrometry (HPLC-MS/MS) was applied in the multicomponent determination of Buddleja lindleyana Fort., and the discrepancies in the contents from ten different habitats were analyzed. The present study simultaneously determined the concentrations of seven chemical compounds of Buddleja lindleyana Fort. extract in rat plasma via HPLC-MS/MS, which was applied in the pharmacokinetic (PK) study of Buddleja lindleyana Fort. A C18 column was used for chromatographic separation, and ion acquisition was achieved by multiple-reaction monitoring (MRM) in negative ionization mode. The optimized mass transition ion-pairs (m/z) for quantization were 591.5/282.8 for linarin, 609.4/300.2 for rutin, 284.9/133.0 for luteolin, 300.6/151.0 for quercetin, 268.8/116.9 for apigenin, 283.0/267.9 for acacetin, 623.3/160.7 for acteoside, and 252.2/155.8 for sulfamethoxazole (IS). A double peak appeared in the drug–time curve of apigenin, which was associated with entero-hepatic recirculation. There were discrepancies in the contents of seven chemical compounds from 10 batches of Buddleja lindleyana Fort., which were associated with the growth environments. Herein, the pharmacokinetic parameters of seven analytes in Buddleja lindleyana Fort. extract are summarized. The maximum plasma concentration (C(max)) of linarin, rutin, luteolin, quercetin, apigenin, acacetin and acteoside were 894.12 ± 9.34 ng mL(−1), 130.76 ± 18.33 ng mL(−1), 77.37 ± 25.72 ng mL(−1), 20.15 ± 24.85 ng mL(−1), 146.42 ± 14.88 ng mL(−1), 31.92 ± 17.58 ng mL(−1), and 649.78 ± 16.42 ng mL(−1), respectively. The time to reach C(max) for linarin, rutin, luteolin, quercetin, apigenin, acacetin, and acteoside were 10, 5, 5, 5, 180, 10 and 10 min, respectively. This is the first report on the simultaneous determination of seven active components for 10 different growing environments and the pharmacokinetic studies of seven active components in rat plasma after the oral administration of Buddleja lindleyana Fort. extract. This study lays the foundation for a better understanding of the absorption mechanism of Buddleja lindleyana Fort., and the evaluation of its clinical application.
format Online
Article
Text
id pubmed-9037101
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90371012022-04-26 The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort. Zhang, Xia Zhang, Zhi-qing Zhang, Li-cang Wang, Ke-xin Zhang, Lan-tong Li, De-qiang RSC Adv Chemistry Buddleja lindleyana Fort., a traditional Chinese medicine, has demonstrated anti-inflammatory, immunomodulatory, antidementia, neuroprotective, antibacterial, and antioxidant effects. Its flowers, leaves, and roots have been used as traditional Chinese medicines. A simple and rapid high-performance liquid chromatography method coupled with mass spectrometry (HPLC-MS/MS) was applied in the multicomponent determination of Buddleja lindleyana Fort., and the discrepancies in the contents from ten different habitats were analyzed. The present study simultaneously determined the concentrations of seven chemical compounds of Buddleja lindleyana Fort. extract in rat plasma via HPLC-MS/MS, which was applied in the pharmacokinetic (PK) study of Buddleja lindleyana Fort. A C18 column was used for chromatographic separation, and ion acquisition was achieved by multiple-reaction monitoring (MRM) in negative ionization mode. The optimized mass transition ion-pairs (m/z) for quantization were 591.5/282.8 for linarin, 609.4/300.2 for rutin, 284.9/133.0 for luteolin, 300.6/151.0 for quercetin, 268.8/116.9 for apigenin, 283.0/267.9 for acacetin, 623.3/160.7 for acteoside, and 252.2/155.8 for sulfamethoxazole (IS). A double peak appeared in the drug–time curve of apigenin, which was associated with entero-hepatic recirculation. There were discrepancies in the contents of seven chemical compounds from 10 batches of Buddleja lindleyana Fort., which were associated with the growth environments. Herein, the pharmacokinetic parameters of seven analytes in Buddleja lindleyana Fort. extract are summarized. The maximum plasma concentration (C(max)) of linarin, rutin, luteolin, quercetin, apigenin, acacetin and acteoside were 894.12 ± 9.34 ng mL(−1), 130.76 ± 18.33 ng mL(−1), 77.37 ± 25.72 ng mL(−1), 20.15 ± 24.85 ng mL(−1), 146.42 ± 14.88 ng mL(−1), 31.92 ± 17.58 ng mL(−1), and 649.78 ± 16.42 ng mL(−1), respectively. The time to reach C(max) for linarin, rutin, luteolin, quercetin, apigenin, acacetin, and acteoside were 10, 5, 5, 5, 180, 10 and 10 min, respectively. This is the first report on the simultaneous determination of seven active components for 10 different growing environments and the pharmacokinetic studies of seven active components in rat plasma after the oral administration of Buddleja lindleyana Fort. extract. This study lays the foundation for a better understanding of the absorption mechanism of Buddleja lindleyana Fort., and the evaluation of its clinical application. The Royal Society of Chemistry 2021-07-28 /pmc/articles/PMC9037101/ /pubmed/35479475 http://dx.doi.org/10.1039/d1ra04154a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Zhang, Xia
Zhang, Zhi-qing
Zhang, Li-cang
Wang, Ke-xin
Zhang, Lan-tong
Li, De-qiang
The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.
title The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.
title_full The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.
title_fullStr The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.
title_full_unstemmed The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.
title_short The development and validation of a sensitive HPLC-MS/MS method for the quantitative and pharmacokinetic study of the seven components of Buddleja lindleyana Fort.
title_sort development and validation of a sensitive hplc-ms/ms method for the quantitative and pharmacokinetic study of the seven components of buddleja lindleyana fort.
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037101/
https://www.ncbi.nlm.nih.gov/pubmed/35479475
http://dx.doi.org/10.1039/d1ra04154a
work_keys_str_mv AT zhangxia thedevelopmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT zhangzhiqing thedevelopmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT zhanglicang thedevelopmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT wangkexin thedevelopmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT zhanglantong thedevelopmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT lideqiang thedevelopmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT zhangxia developmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT zhangzhiqing developmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT zhanglicang developmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT wangkexin developmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT zhanglantong developmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort
AT lideqiang developmentandvalidationofasensitivehplcmsmsmethodforthequantitativeandpharmacokineticstudyofthesevencomponentsofbuddlejalindleyanafort